Bain Capital Life Sciences Investors, LLC Long-Term Concentrated

CIK: 0001703031 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 12, 2024

Total Value ($000): $910,842 (100.0% shares, 0.0% debt)

Holdings (25)

NUVL NUVALENT INC 22.5%
Value ($000) $204,615 Shares 2,697,267 Est. Cost $28.96 Unrealized +145.6%
NAMS NEWAMSTERDAM PHARMA COMPANY 22.1%
Value ($000) $201,204 Shares 10,473,913 Est. Cost $10.64 Unrealized +88.6%
IRON DISC MEDICINE INC 8.9%
Value ($000) $80,934 Shares 1,795,735 Est. Cost $25.40 Unrealized +33.8%
DNTH DIANTHUS THERAPEUTICS INC 8.6%
Value ($000) $77,987 Shares 3,013,423 Est. Cost $21.73 Unrealized +10.6%
PHVS PHARVARIS N V 6.8%
Value ($000) $62,104 Shares 3,303,381 Est. Cost $23.89 Unrealized -14.8%
SVRA SAVARA INC 6.4%
Value ($000) $58,699 Shares 14,565,457 Est. Cost $1.94 Unrealized +129.8%
ANNX ANNEXON INC 4.5%
Value ($000) $41,401 Shares 8,449,208 Est. Cost $11.24 Unrealized -54.0%
KYTX KYVERNA THERAPEUTICS INC 2.8%
Value ($000) $25,263 Shares 3,368,370 Est. Cost $27.08 Unrealized -43.6%
TNGX TANGO THERAPEUTICS INC 2.7%
Value ($000) $24,819 Shares 2,892,663 Est. Cost $10.01 Unrealized -22.8%
SLDB SOLID BIOSCIENCES INC 2.5%
Value ($000) $22,876 Shares 4,034,582 Est. Cost $7.18 Unrealized +24.7%
MERSANA THERAPEUTICS INC 1.9%
Value ($000) $17,414 Shares 8,663,673 Est. Cost $12.65 Unrealized
SYRS SYROS PHARMACEUTICALS INC 1.6%
Value ($000) $14,189 Shares 2,749,808 Est. Cost $5.62 Unrealized -6.5%
IPSC CENTURY THERAPEUTICS INC 1.5%
Value ($000) $13,796 Shares 5,410,361 Est. Cost $3.16 Unrealized 0.0%
CABA CABALETTA BIO INC 1.4%
Value ($000) $12,342 Shares 1,649,964 Est. Cost $10.88 Unrealized +12.6%
X4 PHARMACEUTICALS INC 1.1%
Value ($000) $9,811 Shares 16,915,784 Est. Cost $2.22 Unrealized
ARQT ARCUTIS BIOTHERAPEUTICS INC 1.1%
Value ($000) $9,586 Shares 1,030,703 Est. Cost $26.87 Unrealized -66.3%
AVIR ATEA PHARMACEUTICALS INC 0.9%
Value ($000) $8,227 Shares 2,485,638 Est. Cost $32.23 Unrealized -88.4%
RPID RAPID MICRO BIOSYSTEMS INC 0.6%
Value ($000) $5,567 Shares 8,434,560 Est. Cost $20.66 Unrealized -95.9%
CCCC C4 THERAPEUTICS INC 0.6%
Value ($000) $5,137 Shares 1,111,910 Est. Cost $29.00 Unrealized -79.4%
NAUT NAUTILUS BIOTECHNOLOGY INC 0.5%
Value ($000) $4,680 Shares 2,000,000 Est. Cost $10.83 Unrealized -75.9%
XLO XILIO THERAPEUTICS INC 0.4%
Value ($000) $3,587 Shares 3,785,450 Est. Cost $12.91 Unrealized -91.3%
MARINUS PHARMACEUTICALS INC 0.3%
Value ($000) $2,653 Shares 2,267,680 Est. Cost $9.96 Unrealized
IVVD INVIVYD INC 0.2%
Value ($000) $1,980 Shares 1,799,595 Est. Cost $37.11 Unrealized -94.0%
ACRS ACLARIS THERAPEUTICS INC 0.1%
Value ($000) $1,100 Shares 1,000,000 Est. Cost $12.42 Unrealized -90.5%
NAMSW NEWAMSTERDAM PHARMA COMPANY 0.1%
Value ($000) $872 Shares 100,000 Est. Cost $0.00 Unrealized